NCT02726074View on ClinicalTrials.gov

Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

May 3, 2016

Primary Completion Date

April 26, 2018

Study Completion Date

April 26, 2018

Conditions
Epilepsy
Interventions
DRUG

Perampanel

Trial Locations (6)

Unknown

Busan

Daegu

Daejeon

Gwangju

Seongnam

Seoul

All Listed Sponsors
lead

Eisai Korea Inc.

INDUSTRY

NCT02726074 - Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization | Biotech Hunter | Biotech Hunter